Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus

Clinical and Experimental Immunology

Volumn 150, Issue 3, 2007, Pages 518-522

  Pandey, J P ^a   Montes Cano, M A ^b   Aguilar Reina, J ^b   Gonzalez Escribano, M F ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Allotypes; GM; HCV; HLA; KM

Indexed keywords

HLA ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN;

ARTICLE; CLEARANCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERSISTENT INFECTION; PRIORITY JOURNAL;

EPISTASIS, GENETIC; FEMALE; GENES, IMMUNOGLOBULIN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HUMANS; IMMUNOGLOBULIN GM ALLOTYPES; IMMUNOGLOBULIN KM ALLOTYPES; MALE;

EID: 36048992385     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03519.x     Document Type: Article

References (27)

1. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec 1997 72 : 341 8.
2. Huang Y, Yang H, Borg BB et al. A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci USA 2007 104 : 985 90.
3. Lloyd AR, Jagger E, Post JJ et al. Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection. Immunol Cell Biol 2007 85 : 24 32.
4. Pandey JP, Astemborski J, Thomas DL. Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus. J Virol 2004 78 : 4561 5.
5. Vejbaesya S, Tanwandee T, Pandey JP. Immunoglobulin GM and KM genotypes in hepatitis C virus infection. J Med Virol 2004 73 : 384 6.
6. Steinberg AG, Cook CE. The distribution of human immunoglobulin allotypes. New York : Oxford University Press, 1981.
7. Cheng PN, Marcellin P, Bacon B et al. Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients. J Viral Hepat 2004 11 : 418 26.
8. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000 284 : 450 6.
9. Granoff DM, Boies E, Squires J et al. Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease. J Immunogenet 1984 11 : 181 8.
10. Petersen GM, Silimperi DR, Rotter JI et al. Genetic factors in Haemophilus influenzae type b disease susceptibility and antibody acquisition. J Pediatr 1987 110 : 228 33.
11. Khakoo SI, Thio CL, Martin MP et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004 305 : 872 4.
12. Balbín M, Grubb A, Abrahamson M, Grubb R. Determination of allotypes G1m(f) and G1m(z) at the genomic level by subclass-specific amplification of DNA and use of allele-specific probe. Exp Clin Immunogenet 1991 8 : 88 95.
13. Montes-Cano MA, Caro-Oleas JL, Romero-Gomez M et al. HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 2005 66 : 1106 9.
14. Morahan G, Berek C, Miller JFAP. An idiotypic determinant formed by both immunoglobulin constant and variable regions. Nature 1983 301 : 720 2.
15. Moxley G, Gibbs RS. Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment. Genomics 1992 13 : 104 8.
16. H1 constant region domain modulate antigen binding affinity of antibodies? J Clin Invest 1996 98 : 2235 43.
17. Torres M, Fernandez-Fuentes N, Fiser A, Casadevall A. The immunoglobulin heavy chain constant region affects kinetic and thermodynamic parameters of antibody variable region interactions with antigen. J Biol Chem 2007 282 : 13917 27.
18. Maillard P, Krawczynski K, Nitkiewicz J et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 2001 75 : 8240 50.
19. Maillard P, Lavergne JP, Siberil S et al. Fcγ receptor-like activity of hepatitis C virus core protein. J Biol Chem 2004 279 : 2430 7.
20. Namboodiri AM, Budkowska A, Nietert PJ, Pandey JP. Fcγ receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes. Mol Immunol 2007 44 : 3805 8.
21. Ward JP, Bonaparte MI, Barker E. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS 2004 18 : 1769 79.
22. Herzer K, Falk CS, Encke J et al. Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol 2003 77 : 8299 309.
23. Nattermann J, Schneiders AM, Leifeld L et al. Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). J Hepatol 2005 42 : 499 504.
24. Pandey JP. Genetic polymorphism of Fc. Science 2006 311 : 1376 7.
25. Goddard KA, Hopkins PJ, Hall JM, Witte JS. Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am J Hum Genet 2000 66 : 216 34.
26. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007 39 : 226 31.
27. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998 316 : 1236 8.